The week of April 4, 2011 the Globe & Mail ran extensive coverage on Canadian drug access issues in a series entitled Time to Lead, exploring catastrophic drug coverage, rare disease issues
and international comparisons. The series opened with Andre Picard's article "The Cost of Drugs: Breaking the Bank to Stay Alive" [1], featuring interviews with Dr. Katharina Kovacs-Burns and Linda Wilhelm of the Best Medicines Coalition's Operating Committee, along with other compelling patient stories.
_________________________________________________________________
THE COST OF DRUGS: BREAKING THE BANK TO STAY ALIVE
Monday April 4, 2011: "National Drug Policy For Rare Diseases Has Fallen Between The Cracks" [3]
Tuesday April 5, 2011: "Lack of Catastrophic Drug Program A Black Eye For Canada" [4]
Tuesday April 5, 2011: "How to Reduce Ruinous Drug Costs" [5]
Wednesday April 6, 2011: "Action, Not Excuses, on Drug Coverage" [6]
Thursday April 7, 2011: "Avastin Debate Highlights Challenges of Catastrophic Drug Program" [7]
The Best Medicines Coalition will continue to follow the Globe &
Mail and all media coverage of the catastrophic drug program as the Canadian federal
election approaches and post pertinent updates on the News section of
our website.
Links:
[1] http://www.theglobeandmail.com/news/national/time-to-lead/the-cost-of-drugs-breaking-the-bank-to-stay-alive/article1969308/
[2] http://www.theglobeandmail.com/news/national/time-to-lead/drug-costs-shouldnt-impoverish-canadians/article1969336/
[3] http://www.theglobeandmail.com/news/national/time-to-lead/national-drug-policy-for-rare-diseases-has-fallen-between-the-cracks/article1970960/
[4] http://www.theglobeandmail.com/news/national/time-to-lead/lack-of-catastrophic-drug-program-a-black-eye-for-canada/article1972570/
[5] http://www.theglobeandmail.com/news/opinions/opinion/how-to-reduce-ruinous-drug-costs/article1970566/
[6] http://www.theglobeandmail.com/life/health/new-health/andre-picard/action-not-excuses-on-drug-coverage/article1973673/
[7] http://www.theglobeandmail.com/news/national/time-to-lead/avastin-debate-highlights-challenges-of-a-catastrophic-drug-program/article1974103/